At Genet, we are dedicated to advancing clinical cancer research by providing state-of-the-art liquid biopsy solutions that combine the power of NGS and dPCR. Our platform offers a non-invasive, precise, and comprehensive approach to cancer […]
At Genet, we are devoted to advancing clinical research in the field of colorectal and pancreatic cancer genetics. Our research services focus on various aspects, including: Please note that the information and services provided on […]
Prostate cancer is a common malignancy affecting the prostate gland in men. At Genet, we are committed to advancing clinical research in the field of prostate cancer genetics. Our research services focus on various aspects, […]
Lung cancer is a malignant condition that originates in the lungs and is often divided into two main types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). At Genet, we are committed […]
Breast cancer is a malignant condition that develops in the breast tissue, with invasive ductal carcinoma being the most common form. At Genet, we are committed to advancing clinical research in the field of breast […]
Gynecological cancers encompass a group of malignant conditions that affect the female reproductive system, including ovarian, cervical, uterine, and endometrial cancers. At Genet, we are dedicated to advancing clinical research in the field of gynecological […]
Kidney cancer, also known as renal cancer, is a malignant condition that originates in the kidneys, with the most common type being renal cell carcinoma. At Genet, we are committed to advancing clinical research in […]
Hematologic malignancies encompass a diverse group of cancers that affect the blood, bone marrow, and lymphatic system, including leukemia, lymphoma, and multiple myeloma. At Genet, we are dedicated to advancing clinical research in the field […]
@ Genet Canada Corporation | Website content is for educational and research purposes only and is not intended to be used for medical advice, diagnosis or treatment.